Your session is about to expire
← Back to Search
CHW Sessions + mHealth for HIV/AIDS (CHAMPS Trial)
CHAMPS Trial Summary
This trial is testing a combined community health worker and smartphone intervention linked to a smart pill box for antiretroviral adherence in HIV positive people in the United States. The goal is to see if this intervention enables people to self-manage their antiretroviral regimens while CHW monitor their adherence in real-time, ultimately leading to viral suppression and adherence.
CHAMPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCHAMPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CHAMPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing to follow any treatment plan assigned to me in this study.I was diagnosed with HIV more than 6 months ago.I can communicate and read in English or Spanish.You have a serious illness and are not expected to live for more than 6 months.
- Group 1: Control
- Group 2: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any additional participants sought for this experiment?
"Affirmative. The clinical trial portal, clinicaltrials.gov, reveals that enrollment for this medical trial is open to the public. It was first published on May 3rd 2021 and has been amended as of September 21st 2022. 300 patients are expected to join from three separate sites."
How many participants have registered to partake in this experiment?
"That is correct. According to the clinicaltrials.gov website, this trial has been actively recruiting since May 3rd 2021 and was last modified on September 21st 2022. 300 participants are required from three sites for successful completion of this experiment."
Share this study with friends
Copy Link
Messenger